Galectin Therapeutics Inc <GALT.OQ> expected to post a loss of 16 cents a share - Earnings Preview

• Galectin Therapeutics Inc GALT.OQ GALT.O is expected to report results on March 27 (estimated) for the period ending December 31 2024

• ​LSEG's mean analyst estimate for Galectin Therapeutics Inc is for a loss of 16 cents per share.

• The one available analyst rating on the shares is "hold".

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Galectin Therapeutics Inc is $11.00​, above​ its last closing price of $1.65. ​​​

This summary was machine generated March 25 at 12:32 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)